Parkinson's Drug May Delay Or Prevent Age-Related Blindness

by Shirley Johanna on  November 11, 2015 at 10:06 AM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

A drug used to treat Parkinson's disease may be able to prevent a common form of blindness among older people, says a new research.
Parkinson's Drug May Delay Or Prevent Age-Related Blindness
Parkinson's Drug May Delay Or Prevent Age-Related Blindness

Researchers discovered a biological connection between darker pigmented eyes, which are known to be resistant to Age-related macular degeneration (AMD), and increased levels of a chemical called L-DOPA in those eyes.

L-DOPA is frequently prescribed for Parkinson's patients. They reported that patients receiving L-DOPA were significantly less likely to get AMD, and when they did, its onset was significantly delayed.

Senior author Brian McKay of the University of Arizona said that rather than looking at what might cause AMD, they instead wondered why certain people were protected from AMD.

BrightFocus president Stacy Pagos Haller said that this exciting breakthrough showed the power of scientific discovery to give hope to millions of people across the nation and the world. The study is published in the American Journal of Medicine.

Source: ANI

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Amoebic Dysentery Signature Drug Toxicity Blindness Facts Best Disease Usher Syndrome 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...